Published in Leukemia on August 01, 2005
Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol (2012) 3.43
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood (2008) 3.18
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation. Blood (2014) 1.78
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation. J Clin Oncol (2013) 1.59
Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum Immunol (2007) 1.43
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant (2009) 1.41
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood (2010) 1.30
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies. Tissue Antigens (2013) 1.22
What is the role for donor natural killer cells after nonmyeloablative conditioning? Biol Blood Marrow Transplant (2009) 1.16
Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies. Front Immunol (2014) 1.10
Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies. Leukemia (2009) 0.97
A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. Clin Immunol (2007) 0.96
Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection. Biol Blood Marrow Transplant (2011) 0.96
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant (2009) 0.94
Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors. Bone Marrow Transplant (2008) 0.92
Use of natural killer cells as immunotherapy for leukaemia. Best Pract Res Clin Haematol (2008) 0.91
Hunting for clinical translation with innate-like immune cells and their receptors. Leukemia (2013) 0.86
Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy. Biol Blood Marrow Transplant (2009) 0.86
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant (2015) 0.85
Role of KIR3DS1 in human diseases. Front Immunol (2012) 0.83
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. Semin Immunopathol (2008) 0.82
Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis. Pediatr Blood Cancer (2014) 0.80
α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics. Blood (2014) 0.78
The role of NK cells in HIV-1 protection: autologous, allogeneic or both? AIDS Res Ther (2016) 0.77
Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation. Biol Blood Marrow Transplant (2016) 0.77
HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation. Biomedicines (2017) 0.76
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing. Front Immunol (2017) 0.75
Partial break in tolerance of NKG2A(-)/LIR-1(-) single KIR(+) NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation. Bone Marrow Transplant (2017) 0.75
NK cell receptors and their ligands in leukemia. Leukemia (2007) 1.78
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol (1994) 1.58
HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology (1999) 1.56
Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. Eur J Clin Nutr (2007) 1.50
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia (2003) 1.43
Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) DNA sequences are absent in leukapheresis products and ex vivo expanded CD34+ cells from multiple myeloma patients. Br J Haematol (1999) 1.38
Static and dynamic roentgenographic analysis of ankle stability in braced and nonbraced stable and functionally unstable ankles. Am J Sports Med (1998) 1.20
Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol (2002) 1.12
Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol (2001) 1.10
Pain threshold in patients with rheumatoid arthritis and effect of manual oscillations. Scand J Rheumatol (1999) 1.07
Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest (1998) 1.07
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay. Scand J Immunol (2003) 1.06
Relationship of obesity with physical activity, aerobic fitness and muscle strength in Flemish adults. J Sports Med Phys Fitness (2008) 1.04
Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during aging. Biogerontology (2004) 1.04
Control of acceleration during sudden ankle supination in people with unstable ankles. J Orthop Sports Phys Ther (2001) 1.00
Progressive paraparesis due to thoracic extramedullary hematopoiesis in myelofibrosis. Case report. J Neurosurg (1993) 0.97
Markers of infection and their relationship to preterm delivery. Am J Perinatol (1995) 0.95
Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient. Eur J Haematol (2000) 0.95
Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia (2004) 0.93
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease. Q J Nucl Med Mol Imaging (2007) 0.92
Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod (2002) 0.90
The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol (2006) 0.90
Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod (2004) 0.89
Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. J Immunol (1991) 0.89
Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation. Bone Marrow Transplant (2000) 0.89
Long-term survival in an adult metastatic renal peripheral primitive neuroectodermal tumor (PPNET) with multimodality treatment including high-dose chemotherapy. Ann Oncol (1997) 0.88
Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. Br J Haematol (1991) 0.88
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol (2011) 0.88
Immune dysfunction associated with chronic professional stress in nurses. Psychiatry Res (1999) 0.88
Inflammation-related muscle weakness and fatigue in geriatric patients. Exp Gerontol (2011) 0.87
Lymphedema development following breast cancer surgery with full axillary resection. Lymphology (2004) 0.86
Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. Eur J Haematol (1996) 0.85
Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax. Eur Respir J (2004) 0.85
Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. Eur J Haematol (2001) 0.85
Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2). Leukemia (1997) 0.84
The prevalence of autoantibodies in an elderly sub-Saharan African population. Clin Exp Immunol (2002) 0.83
Tracking of adult adiposity in early, average and late maturing children: a thirty year longitudinal growth study. J Sports Med Phys Fitness (2008) 0.81
Production and characterization of bispecific single-chain antibody fragments. Mol Immunol (1995) 0.81
Bayesian estimation of the parameters of a nonlinear model. An application to human height. Growth Dev Aging (1997) 0.81
Reproducibility and reliability of measurements using a linear isokinetic dynamometer, Aristokin. J Sports Med Phys Fitness (2001) 0.81
Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphoma. Adv Exp Med Biol (1993) 0.81
Objective roentgenologic measurements of the influence of ankle braces on pathologic joint mobility. A comparison of 9 braces. Acta Orthop Belg (1998) 0.81
Production of fibronectin and adherence to fibronectin by human myeloma cell lines. Br J Haematol (1994) 0.80
Belgian consensus recommendations for flow cytometric immunophenotyping. The Belgian Association for Cytometry/Belgische Vereniging voor Cytometrie/Association Belge de Cytométrie. Acta Clin Belg (1999) 0.79
Differential cytology of bronchoalveolar lavage fluid in asthmatic children. Pediatr Pulmonol (2003) 0.79
Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance. Am J Clin Pathol (1990) 0.79
Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT. Bone Marrow Transplant (2009) 0.79
Circulating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells. Eur J Haematol (1998) 0.79
Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens (2000) 0.79
Disability evaluation in chronic fatigue syndrome: associations between exercise capacity and activity limitations/participation restrictions. Clin Rehabil (2004) 0.78
Anthropometric fractionation of body mass: Matiegka revisited. J Sports Sci (2002) 0.78
Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia (2006) 0.78
The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol (1999) 0.78
Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myeloma. Br J Haematol (1997) 0.78
Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts. Eur J Haematol (1999) 0.78
Circulating heat shock protein 70 (Hsp70) in elderly members of a rural population from Cameroon: association with infection and nutrition. Arch Gerontol Geriatr (2011) 0.77
Enhanced assessment of allogeneic bone marrow transplant engraftment using automated fluorescent-based typing. Bone Marrow Transplant (1999) 0.77
Bispecific antibody treatment of murine B cell lymphoma. Cancer Immunol Immunother (1998) 0.77
Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in a 11-year-old boy. Eur J Pediatr (1999) 0.76
Adding compression to mobilization in a rehabilitation program after knee surgery. A preliminary clinical observational study. Man Ther (2000) 0.76
Lack of impairment of kinaesthetic sensibility in cervicogenic headache patients. Cephalalgia (2008) 0.76
Men with atherosclerotic stenosis of the carotid artery have lower testosterone levels compared with controls. Int Angiol (2008) 0.76
Hypo-IgG in myotonic dystrophy is due to a selective reduction of the IgG1-subclass serum level. Muscle Nerve (1994) 0.75
Suspected "t-cell-mediated" hypereosinophilic syndrome presenting with cerebral watershed infarcts. Case Rep Neurol Med (2011) 0.75
Guidelines for an integrated diagnostic approach of chronic lymphoproliferative disorders in the routine laboratory of haematology in Belgium. Acta Clin Belg (2010) 0.75
The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency. Br J Haematol (1998) 0.75
Malignant lymphoma of the bone. Acta Clin Belg (1990) 0.75
Bispecific antibodies in lymphoma. Int Rev Immunol (1993) 0.75
Extramedullary plasmacytoma of the cavernous sinus. Leuk Lymphoma (2002) 0.75
Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma. Acta Clin Belg (1990) 0.75
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica (1999) 0.75
Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1992) 0.75
G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release. Clin Rheumatol (1995) 0.75
Peripheral blood stem cell transplantation. Acta Clin Belg (1993) 0.75
Characterization of a new DRB4 allele (DRB4*0104). Tissue Antigens (1996) 0.75
A computer program for calculating the Health-Carter anthropometric somatotype. J Sports Med Phys Fitness (1977) 0.75
Cytokeratin expression by CD34 positive blasts in a case of refractory anaemia with excess of blasts in transformation (RAEB-t). J Clin Pathol (2001) 0.75
Will the use of different prevalence rates influence the development of a primary prevention programme for low-back problems? Ergonomics (2000) 0.75
[Endomorphy in childhood and adolescence as predictor of aerobic capacity]. Sportverletz Sportschaden (2004) 0.75
Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium. Acta Clin Belg (2011) 0.75
Neuroblastoma today. Biomed Pharmacother (1988) 0.75
A new silent mutation at codon 35 in exon 2 yielding DRB1*04012 allele. Tissue Antigens (1997) 0.75
Different expression of adhesion molecules on myeloid and B-lymphoid CD34+ progenitors in normal bone marrow. Eur J Haematol (1997) 0.75
Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6. Tissue Antigens (2012) 0.75
On the variability of some physical fitness parameters in boys 6-13 years of age. J Sports Med Phys Fitness (1974) 0.75
A method for detecting errors in data of growth studies. Ann Hum Biol (1980) 0.75
Reversible cardiopathy after accidental overdose of mitoxantrone. Pediatr Hematol Oncol (1993) 0.75